SIGA Technologies (SIGA) Receiving Somewhat Positive Press Coverage, Report Finds
Headlines about SIGA Technologies (NASDAQ:SIGA) have trended somewhat positive recently, according to Accern. Accern identifies negative and positive news coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. SIGA Technologies earned a news sentiment score of 0.01 on Accern’s scale. Accern also assigned headlines about the biotechnology company an impact score of 45.9130846513114 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.
SIGA Technologies (SIGA) opened at 2.98 on Tuesday. The company’s market cap is $235.15 million. SIGA Technologies has a 1-year low of $1.90 and a 1-year high of $3.88. The stock’s 50 day moving average price is $3.06 and its 200-day moving average price is $3.23.
SIGA Technologies Company Profile
SIGA Technologies, Inc is engaged in the development and commercialization of solutions for various unmet medical needs and biothreats. The Company’s lead product is TPOXX, an orally administered antiviral drug that targets orthopoxviruses infections. TPOXX is a small-molecule drug delivered to the Strategic Stockpile under the Project BioShield Act of 2004 (Project BioShield).
Receive News & Stock Ratings for SIGA Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SIGA Technologies Inc. and related stocks with our FREE daily email newsletter.